David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
CALL
Fair Isaac
FICO
$24.5B
| $5.24M | 0.01% |
19,300
+13,300
| +222% | +$3.12M |
|
1477
FirstCash
FCFS
$9.53B
| $5.23M | 0.01% |
60,459
-41,226
| -41% | -$3.44M |
|
1478
Metallus
MTUS
$804M
| $5.23M | 0.01% |
481,486
-17,622
| -4% | -$203K |
|
1479
CALL
Carvana
CVNA
$81.3B
| $5.21M | 0.01% |
449,000
-41,000
| -8% | -$345K |
|
1480
RH
RH
$2.81B
| $5.21M | 0.01% |
50,628
+33,052
| +188% | +$4.5M |
|
1481
Ribbon Communications
RBBN
$363M
| $5.2M | 0.01% |
1,010,271
+102,139
| +11% | +$547K |
|
|
TCS
1482
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $5.2M | 0.01% |
39,354
-340
| -0.9% | -$33.5K |
|
|
RYAM.PRA
1483
DELISTED
Rayonier Advanced Materials Inc. 8.00% Series A Mandatory Convertible Preferred Stock
RYAM.PRA
| $5.19M | 0.01% |
52,394
+42,394
| +424% | +$4.19M |
|
|
1484
PUT
Fair Isaac
FICO
$24.5B
| $5.19M | 0.01% |
+19,100
| New | +$4.49M |
|
|
DOO
1485
Bombardier Recreational Products
DOO
$4.42B
| $5.19M | 0.01% |
186,777
+113,785
| +156% | +$3.25M |
|
1486
B&G Foods
BGS
$287M
| $5.18M | 0.01% |
+212,244
| New | +$5.56M |
|
1487
CALL
Whirlpool
WHR
$2.62B
| $5.18M | 0.01% |
39,000
+3,600
| +10% | +$475K |
|
1488
Ryanair
RYAAY
$29.4B
| $5.18M | 0.01% |
172,845
+64,580
| +60% | +$1.87M |
|
1489
PUT
Children's Place
PLCE
$59.4M
| $5.17M | 0.01% |
53,200
+17,400
| +49% | +$1.59M |
|
1490
Stantec
STN
$8.48B
| $5.17M | 0.01% |
218,700
+130,738
| +149% | +$3.1M |
|
1491
PUT
Vail Resorts
MTN
$5.3B
| $5.17M | 0.01% |
23,800
+18,300
| +333% | +$3.74M |
|
1492
CALL
Atlassian
TEAM
$42.6B
| $5.17M | 0.01% |
46,000
+10,100
| +28% | +$1.03M |
|
1493
PUT
McDonald's
MCD
$189B
| $5.17M | 0.01% |
27,200
-63,800
| -70% | -$11.6M |
|
1494
PUT
Campbell Soup
CPB
$6.93B
| $5.16M | 0.01% |
135,400
-90,000
| -40% | -$3.18M |
|
1495
Halozyme
HALO
$12.2B
| $5.15M | 0.01% |
319,986
-82,898
| -21% | -$1.34M |
|
1496
CALL
Alnylam Pharmaceuticals
ALNY
$32B
| $5.14M | 0.01% |
55,000
+4,000
| +8% | +$335K |
|
1497
Mueller Industries
MLI
$14.2B
| $5.13M | 0.01% |
655,392
-46,480
| -7% | -$342K |
|
1498
Danaher
DHR
$151B
| $5.13M | 0.01% |
43,851
-427,688
| -91% | -$43.8M |
|
1499
CALL
Stanley Black & Decker
SWK
$15.1B
| $5.11M | 0.01% |
37,500
-52,500
| -58% | -$6.85M |
|
1500
Linde
LIN
$226B
| $5.09M | 0.01% |
28,939
+5,185
| +22% | +$861K |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.